50
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Comparison of Afamin Values in Umbilical Cord Blood After Delivery in Pregnancies With and Without Gestational Diabetes Mellitus

ORCID Icon, , , , &
Pages 83-93 | Received 31 Oct 2023, Accepted 27 Dec 2023, Published online: 08 Jan 2024

References

  • Guariguata L, Linnenkamp U, Beagley J, Whiting DR, Cho NH. Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract. 2014;103(2):176–85. doi:10.1016/j.diabres.2013.11.003.
  • Ye W, Luo C, Huang J, Li C, Liu Z, Liu F. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2022;377:e067946. doi:10.1136/bmj-2021-067946.
  • Sweeting A, Wong J, Murphy HR, Ross GP. A clinical update on gestational diabetes mellitus. Endocr Rev. 2022;43(5):763–93. doi:10.1210/endrev/bnac003.
  • Dabelea D, Hanson RL, Lindsay RS, Pettitt DJ, Imperatore G, Gabir MM, Roumain J, Bennett PH, Knowler WC. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes. 2000;49(12):2208–11. doi:10.2337/diabetes.49.12.2208.
  • Tam WH, Ma RCW, Ozaki R, Li AM, Chan MHM, Yuen LY, Lao TTH, Yang X, Ho CS, Tutino GE, et al. In utero exposure to maternal hyperglycemia increases childhood cardiometabolic risk in offspring. Diabetes Care. 2017;40(5):679–86. doi:10.2337/dc16-2397.
  • Lorenzo-Almorós A, Hang T, Peiró C, Soriano-Guillén L, Egido J, Tuñón J, Lorenzo Ó. Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases. Cardiovasc Diabetol. 2019;18(1):140. doi:10.1186/s12933-019-0935-9.
  • Lichenstein HS, Lyons DE, Wurfel MM, Johnson DA, McGinley MD, Leidli JC, Trollinger DB, Mayer JP, Wright SD, Zukowski MM. Afamin is a new member of the albumin, alpha-fetoprotein, and vitamin D-binding protein gene family. J Biol Chem. 1994;269(27):18149–54. doi:10.1016/S0021-9258(17)32429-8.
  • Jerkovic L, Voegele AF, Chwatal S, Kronenberg F, Radcliffe CM, Wormald MR, Lobentanz EM, Ezeh B, Eller P, Dejori N, et al. Afamin is a novel human vitamin E-binding glycoprotein characterization and in vitro expression. J Proteome Res. 2005;4(3):889–99. doi:10.1021/pr0500105.
  • Voegele AF, Jerković L, Wellenzohn B, Eller P, Kronenberg F, Liedl KR, Dieplinger H. Characterization of the vitamin E-binding properties of human plasma afamin. Biochemistry. 2002;41(49):14532–8. doi:10.1021/bi026513v.
  • Dieplinger B, Egger M, Gabriel C, Poelz W, Morandell E, Seeber B, Kronenberg F, Haltmayer M, Mueller T, Dieplinger H. Analytical characterization and clinical evaluation of an enzyme-linked immunosorbent assay for measurement of afamin in human plasma. Clin Chim Acta. 2013;425:236–41. doi:10.1016/j.cca.2013.08.016.
  • Kronenberg F, Kollerits B, Kiechl S, Lamina C, Kedenko L, Meisinger C, Willeit J, Huth C, Wietzorrek G, Altmann ME, et al. Plasma concentrations of afamin are associated with the prevalence and development of metabolic syndrome. Circ Cardiovasc Genet. 2014;7(6):822–9. doi:10.1161/CIRCGENETICS.113.000654.
  • Heiser M, Hutter-Paier B, Jerkovic L, Pfragner R, Windisch M, Becker-André M, Dieplinger H. Vitamin E binding protein afamin protects neuronal cells in vitro. J Neural Transm Suppl. 2002;(62):337–45. doi:10.1007/978-3-7091-6139-5_32.
  • Seeber B, Morandell E, Lunger F, Wildt L, Dieplinger H. Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome. Reprod Biol Endocrinol. 2014;12(1):88. doi:10.1186/1477-7827-12-88.
  • Kollerits B, Lamina C, Huth C, Marques-Vidal P, Kiechl S, Seppälä I, Cooper J, Hunt SC, Meisinger C, Herder C, et al. Plasma concentrations of afamin are associated with prevalent and incident type 2 diabetes: a pooled analysis in more than 20,000 individuals. Diabetes Care. 2017;40(10):1386–93. doi:10.2337/dc17-0201.
  • Köninger A, Mathan A, Mach P, Frank M, Schmidt B, Schleussner E, Kimmig R, Gellhaus A, Dieplinger H. Is Afamin a novel biomarker for gestational diabetes mellitus? A pilot study. Reprod Biol Endocrinol. 2018;16(1):30. doi:10.1186/s12958-018-0338-x.
  • International Association of D, Pregnancy Study Groups Consensus P, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, Leiva Ad, Hod M, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–82. doi:10.2337/dc09-1848.
  • Poston L, Caleyachetty R, Cnattingius S, Corvalán C, Uauy R, Herring S, Gillman MW. Preconceptional and maternal obesity: epidemiology and health consequences. Lancet Diabetes Endocrinol. 2016;4(12):1025–36. doi:10.1016/S2213-8587(16)30217-0.
  • Yurtcu E, Mutlu S, Ozkaya E. The effects of pre-pregnancy body mass index and weight gain during pregnancy on perinatal outcomes: a retrospective cohort study. Gynecol Obstet Reprod Med. 2021;28(1):16–22. doi:10.21613/GORM.2021.1149.
  • Neves RO, Rocha ADS, de Vargas BO, Kretzer DC, de Matos S, Goldani MZ, von Diemen L, Magalhaes JAA, Bernardi JR. Obesity cut-off points using prepregnancy body mass index according to cardiometabolic conditions in pregnancy. J Pregnancy. 2023;2023:6669700–7. doi:10.1155/2023/6669700.
  • Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci. 2018;19(11):3342. doi:10.3390/ijms19113342.
  • Wang X, Zheng X, Yan J, Xu R, Xu M, Zheng L, Xu L, Lin Z. The clinical values of afamin, triglyceride and PLR in predicting risk of gestational diabetes during early pregnancy. Front Endocrinol (Lausanne). 2021;12:723650. doi:10.3389/fendo.2021.723650.
  • Ruszała M, Pilszyk A, Niebrzydowska M, Kimber-Trojnar Ż, Trojnar M, Leszczyńska-Gorzelak B. Novel biomolecules in the pathogenesis of gestational diabetes mellitus 2.0. Int J Mol Sci. 2022;23(8):4364. doi:10.3390/ijms23084364.
  • Tramontana A, Dieplinger B, Stangl G, Hafner E, Dieplinger H. First trimester serum afamin concentrations are associated with the development of pre-eclampsia and gestational diabetes mellitus in pregnant women. Clin Chim Acta. 2018;476:160–6. doi:10.1016/j.cca.2017.11.031.
  • Yuan Y, He W, Fan X, Liang J, Cao Z, Li L. Serum afamin levels in predicting gestational diabetes mellitus and preeclampsia: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2023;14:1157114. doi:10.3389/fendo.2023.1157114.
  • Hubalek M, Buchner H, Mörtl MG, Schlembach D, Huppertz B, Firulovic B, Köhler W, Hafner E, Dieplinger B, Wildt L, et al. The vitamin E-binding protein afamin increases in maternal serum during pregnancy. Clin Chim Acta. 2014;434(100):41–7. doi:10.1016/j.cca.2014.03.036.
  • Atakul N, Atamer Y, Selek Ş, Kılıç BS, Unal F. Novel metabolic marker Afamin: a predictive factor for Large-for-Gestational-Age (LGA) fetus estimation in pregnancies with gestational diabetes mellitus? J Gynecol Obstet Hum Reprod. 2021;50(10):102201. doi:10.1016/j.jogoh.2021.102201.
  • Zasada M, Suski M, Bokiniec R, Szwarc-Duma M, Borszewska-Kornacka MK, Madej J, Bujak-Giżycka B, Madetko-Talowska A, Revhaug C, Baumbusch LO, et al. Comparative two time-point proteome analysis of the plasma from preterm infants with and without bronchopulmonary dysplasia. Ital J Pediatr. 2019;45(1):112. doi:10.1186/s13052-019-0676-0.
  • Lindsay RS, Walker JD, Havel PJ, Hamilton BA, Calder AA, Johnstone FD, Scottish Multicentre Study of Diabetes P. Adiponectin is present in cord blood but is unrelated to birth weight. Diabetes Care. 2003;26(8):2244–9. doi:10.2337/diacare.26.8.2244.
  • Roca-Rodríguez MDM, Ramos-García P, López-Tinoco C, Aguilar-Diosdado M. Significance of umbilical cord leptin profile during pregnancy in gestational diabetes mellitus-A systematic review and meta-analysis. J Clin Med. 2023;12(14):4756. doi:10.3390/jcm12144756.
  • Araki T, Haupt H, Hermentin P, Schwick HG, Kimura Y, Schmid K, Torikata T. Preparation and partial structural characterization of alpha1T-glycoprotein from normal human plasma. Arch Biochem Biophys. 1998;351(2):250–6. doi:10.1006/abbi.1997.0564.
  • Pang L, Duan N, Xu D, Jiao L, Huang C, Du J, Guo Q, Li H. Urine afamin and afamin-creatinine ratio as biomarkers for kidney injury. Biomark Med. 2018;12(11):1241–9. doi:10.2217/bmm-2018-0126.
  • Pang L, Li Q, Li Y, Liu Y, Duan N, Li H. Urine proteomics of primary membranous nephropathy using nanoscale liquid chromatography tandem mass spectrometry analysis. Clin Proteomics. 2018;15(1):5. doi:10.1186/s12014-018-9183-3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.